SCHEMBL14864423

SCHEMBL14864423

CCOC(=O)Cc1nnc(NS(=O)(=O)c2ccc(NC=O)cc2)s1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 2/20 0.66
IRS1 P35568 1/20 0.66
GAB1 Q13480 1/20 0.66
PKM P14618 3/20 0.56
HSD17B10 Q99714 2/20 0.56
MEN1 O00255 10/20 0.55
KMT2A Q03164 10/20 0.55
ALDH1A1 P00352 5/20 0.55
MAPT P10636 4/20 0.55
KDM4E B2RXH2 3/20 0.55
HPGD P15428 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
POLB P06746 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
USP2 O75604 1/20 0.51
KLKB1 P03952 1/20 0.51
CTSB P07858 1/20 0.51
ELANE P08246 1/20 0.51
LMNA P02545 1/20 0.50
APEX1 P27695 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL282264 0.86 AKT1 (0.74) AKT1IRS1GAB1PKMHSD17B10
SCHEMBL14864432 0.85 AKT1 (0.71) AKT1IRS1GAB1PKMHSD17B10
SCHEMBL14864426 0.85 AKT1 (0.60) AKT1IRS1GAB1PKMHSD17B10
SCHEMBL14864421 0.85 AKT1 (0.70) AKT1IRS1GAB1PKMHSD17B10
SCHEMBL14864425 0.83 PKM (0.71) AKT1PKMHSD17B10MEN1KMT2A
SCHEMBL14864429 0.83 AKT1 (0.65) AKT1IRS1GAB1PKMHSD17B10
SCHEMBL1413821 0.82 AKT1 (0.76) AKT1IRS1GAB1PKMHSD17B10
SCHEMBL14864418 0.81 AKT1 (0.58) AKT1PKMHSD17B10MEN1KMT2A
SCHEMBL283324 0.81 AKT1 (0.77) AKT1IRS1GAB1PKMHSD17B10
SCHEMBL282664 0.80 AKT1 (1.00) AKT1IRS1GAB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9320734-B2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2016-04-26 US disclosed
US-20150126563-A1 SMALL MOLECULE INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2015-05-07 US disclosed
US-8420678-B2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2013-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150126563-A1 SMALL MOLECULE INHIBITORS OF THE PLECKSTRIN HOMOLOGY DOMAIN AND METHODS FOR USING SAME PLEKHG3, PLEKHA1, PLEC AKT1 92/4885IRS1 1903/4885GAB1 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.